Results 221 to 230 of about 171,385 (240)

Ki‐67 and grading of malignant fibrous histiocytomas

Cancer, 1990
Although generally considered to be of high grade, malignant fibrous histiocytomas (MFH) show a range of histologic appearances and a diverse biologic behavior. More precise grading of this type of sarcoma is desirable. The rate of cell proliferation may reflect clinical behavior.
R J, Zehr, T W, Bauer, K E, Marks, A, Weltevreden   +3 more
openaire   +3 more sources

Ki-67 immunostaining and prognosis in laryngeal cancer

Clinical Otolaryngology and Allied Sciences, 1998
The expression of the antigen defined by the Ki-67 antibody in paraffin sections from 154 biopsies of laryngeal squamous cell carcinomas was examined. There was a significant difference in Ki-67 expression between the control group and the patients with cancer (P < 0.001). There was no significant difference in the Ki-67 score between the patients with
T, Krecicki, M, Jeleń, M, Zalesska-Krecicka, T, Szkudlarek   +3 more
openaire   +2 more sources

Restricted Expression of Ki-67 in Cholesteatoma Epithelium

Archives of Otolaryngology - Head and Neck Surgery, 1993
Proliferative sites within the overgrowing epithelium of cholesteatoma are still ill defined. In this study, we used the monoclonal antibody Ki-67 on frozen cut sections from 23 cholesteatoma samples obtained at surgery from 20 patients. This reagent has been reported to stain the nucleus of proliferating tumor cells and the cytoplasm of growing ...
D, Mayot, M C, Béné, C, Perrin, G C, Faure   +3 more
openaire   +2 more sources

?????????????????????? ????????????/ ?????????????????? ?? ?????????? ?????????????? ?? ???????????????????????? ?????????????? ?????????? ???????????????? ???????????? ?? ???????????????????????????????? Ki-67

2018
Objective: to study peculiarities of the course of breast cancer (BC) with Ki-67 overexpression depending on the area occupied by the tumor stroma. Object and methods: the study included 220 patients with BC (T1N0M0 ??? 19, T2N0M0, T1N1M0 ??? 90, T2N1M0, T3N0M0 ??? 98, T4N0M0 ??? 13).
openaire   +1 more source

Ki-67 index in metastatic prostate cancer.

European urology, 2001
Prostate cancer in bone is generally thought to progress more rapidly than in its primary site, a supposition that is supported by studies of prostate-specific antigen velocity. However, descriptions of proliferative rates in metastases have relied on inferred data from in vitro studies of cell lines derived from metastases.
Bryden, A. A G, Freemont, A. J.; id_orcid 0000-0002-9780-208X, Clarke, N. W., George, N. J R   +3 more
openaire   +2 more sources

Getting a Grip on Ki-67

Applied Immunohistochemistry & Molecular Morphology, 2021
openaire   +2 more sources

The role of Ki-67 in breast cancer.

South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie, 2016
The proliferative marker, Ki-67, is a human nuclear antigen, and forms an integral part of cell division in both normal and malignant tissue. Since the hallmark of cancer is uncontrolled and relentless cell proliferation, the Ki-67 proliferative index is increasingly used to assess and manage breast cancer. The value of Ki-67 as a prognostic indicator,
openaire   +3 more sources

IMMUNOHISTOCHEMICAL EVALUATION OF KI-67 IN ODONTOGENIC KERATOCYSTS

2000
-
D'ARCANGELO, Camillo, CORINA V, VARVARA G, DE FAZIO, Pietro, TETE', Stefano, FALCO A., PERFETTI, Giorgio   +6 more
openaire   +2 more sources

P53 and Ki-67 in proliferative skin diseases

Acta Dermatovenerologica Croatica, 2003
P53 and Ki-67 in proliferative skin ...
Stašić, Adalbert, Lipozenčić, Jasna, Zamolo, Gordana, Gruber, Franjo, Lenković, Maja, Batinac, Tanja   +5 more
openaire   +3 more sources

Ki-67

Advances in Anatomic Pathology, 1996
openaire   +1 more source